Ecco finalmente disponibile in italiano un testo che sin dalla sua prima edizione, nel 1992, si è rivelato un’indispensabile guida per la comprensione di una scienza giovane dai rapidi e promettenti sviluppi.
In 2006, when my colleague Andrea Renda proposed multiple primary malignancies (MPM) as the subject of the Biennial Report to the 2008 Congress of the Italian - ciety of Surgery, I, together with the Steering Committee, quickly agreed.
Il volume si propone di esaminare la struttura e le funzioni dei recettori dell’angiotensina e le ricadute delle conoscenze acquisite sull’argomento sul piano terapeutico.
Una epidemia nutricional marcará el siglo XXI: las enfermedades infecciosas han dejado de ser la principal causa de mortalidad y en su lugar aparecen como primera causa las enfermedades derivadas de una mala nutrición.
This book offers a valuable contribution to contemporary legal literature, providing deep insights into the interface between law and genetics, highlighting emerging issues and providing meaningful solutions to current problems.
"e;Omics for Personalized Medicine"e; will give to its prospective readers the insight of both the current developments and the future potential of personalized medicine.
This two-volume set provides a general overview of the evolution of the human genome; The first volume overviews the human genome with descriptions of important gene groups.
This book proposes immunogenomics, or immunopharmacogenomics, as the next-generation big science to uncover the role that the immune system plays in the pathogenesis of many diseases, by summarizing the importance of the deep sequencing of T-cell and B-cell receptors.
This book presents recent advances in translational research on muscular dystrophy (MD) to physicians and researchers, including cutting-edge research on the disease such as regenerative medicine, next-generation DNA sequencing, and nucleic acid therapies.
This book reports the recent progress in gene and cell therapy through the liver and aims to facilitate a comprehensive understanding of the current aspects and future prospects from basic research to clinical therapies.
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease.
The research described in this book represents important steps toward understanding the development of inner ear medicine and new perspectives in regenerative medicine, including efficacy in cochlear implants and various other treatments.
The discovery in the late 1940's that sickle cell anemia is a "e;molecular disease"e; of hemoglobin was the crucial advance that gave birth to the scientific discipline of human molecular genetics.
With the advent of genetic engineering methods and improved biochemical tech- niques, much has been learned about the replication of influenza viruses, their structure and their epidemiology.
Schizophrenia has been the subject of intense research interest in recent years, as investigators have explored the biological bases for the disorder and for various approaches to its diagnosis and treatment.
As President and organiser of the 26th Congress of the International Society pf Blood Transfusion 'ISBT 2000', I am pleased to introduce this work on the biochemistry of human blood groups, which will serve as a valuable complement to blood group serology work.
Expert clinicians and basic scientists with a special interest in Parkinson's disease review the current state of science and clinical therapeutics of the disease.
Dieser Buchtitel ist Teil des Digitalisierungsprojekts Springer Book Archives mit Publikationen, die seit den Anfängen des Verlags von 1842 erschienen sind.
Although a few books covering primarily serological aspects of human blood groups are available, it became clear to me in the course of my research that no compendium of the non-serological aspects of human blood group systems exists.
This book provides comprehensive insights into congenital heart disease from embryonic development through to clinical features, including human genetics and our current knowledge of the underlying molecular pathways.
